Stratum Nutrition and its Indian partner, Zenova Bionutrition Pvt. Ltd., were granted pre-market approval of its NEM brand partially hydrolyzed chicken eggshell membrane powder from the Food Safety Standards Authority of India
Stratum Nutrition (Carthage, MO) and its Indian partner, Zenova Bionutrition Pvt. Ltd., were granted pre-market approval of its NEM brand partially hydrolyzed chicken eggshell membrane powder from the Food Safety Standards Authority of India (FSSAI) in October 2021.
“We are extremely gratified to receive approval from FSSAI, as this again validates the substantial scientific portfolio that supports NEM and its health claims,” said Kevin J. Ruff, PhD, MBA, sr. director of scientific & regulatory affairs for Stratum Nutrition, in a press release. “NEM, being ovo-vegetarian, makes a great combination with curcumin-based ingredients for joint health, and this approval should allow NEM to establish its place as an innovative, science-backed ingredient in India’s consumer market.”
NEM is a joint-health ingredient that is supported by a full portfolio of 16 research studies, including four randomized placebo-controlled trials, four open-label clinical trials, veterinary trials, and a wide range of supporting in vitro and in vivo mechanism of action studies.
“The long-term scientific efforts by Stratum to increase global acceptance of NEM as a joint health ingredient, which is fundamental for the health and well-being of the global population, continues. NEM’s exponential success of country-by-country registration clearly demonstrates the scientific validation of its function and results,” said Chris Haynes, senior director of global sales for Stratum Nutrition. “Governmental agencies require statistically significant science to grant approvals – NEM provides this and continues to gain regulatory acceptance everywhere it enters a market. India will be a solid and strategic market for Stratum moving forward.”